Abstract
Actinic keratosis (AK) is the most common precancerous skin lesion. AKs present on sun-damaged skin as pink to red gritty macules or papules. Patients with numerous AKs are at increased risk of developing skin cancer. AK development represents the initial step in keratinocytes’ progression to squamous cell carcinoma. Patients with numerous AKs are at increased risk of developing skin cancer. Treatment options for AKs include cryosurgery, topical chemotherapies, chemical peels, and laser surgery. Prevention is of utmost importance, including photoprotection such as sun protective clothing and sunscreens.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Rosen T, Lebwohl MG. Prevalence and awareness of actinic keratosis: barriers and opportunities. J Am Acad Dermatol. 2013;68(1):S2–9.
James WD, Elston DM, Berger TG, Elston DM. Epidermal nevi, neoplasms, and cysts. In: James WD, Berger TG, Elston DM, editors. Andrews' diseases of the skin. 12th ed. Philadelphia: Elsevier; 2016.
Chen GJ, Feldman SR, Williford PM, Hester EJ, Kiang S-H, Gill I, et al. Clinical diagnosis of actinic keratosis identifies an elderly population at high risk of developing skin cancer. Dermatol Surg. 2005;31(1):43–7.
Dodson JM. Malignant potential of actinic keratoses and the controversy over treatment. A patient-oriented perspective. AMA Dermatol. 1991;127(7):1029–31.
Roewert-Huber J, Stockfleth E, Kerl H. Pathology and pathobiology of actinic (solar) keratosis - an update. Br J Dermatol. 2007;157(s2):18–20.
Nair PA, Chaudhary AH, Mehta MJ. Actinic keratosis underlying cutaneous horn at an unusual site— a case report. E Cancer Med Sci. 2013;7:376.
Soyer HP, Rigel DS, Wurm EMT. Actinic keratosis, basal cell carcinoma and squamous cell carcinoma. In: Bolognia J, Jorizzo JL, Schaffer JV, editors. Dermatology. 3rd ed. Philadelphia: Elsevier; 2012.
Zalaudek I, Ferrara G, Leinweber B, Mercogliano A, D'Ambrosio A, Argenziano G. Pitfalls in the clinical and dermoscopic diagnosis of pigmented actinic keratosis. J Am Acad Dermatol. 2005 Dec;53(6):1071–4.
Bagazgoitia L, Cuevas J, Expression JA. Of p53 and p16 in actinic keratosis, bowenoid actinic keratosis and Bowen's disease. J Eur Acad Dermatol Venereol. 2005;24(2):228–30.
Rowert-Huber J, Patel MJ, Forschner T, Ulrich C, Eberle J, Kerl H, et al. Actinic keratosis is an early in situ squamous cell carcinoma: a proposal for reclassification. Br J Dermatol. 2007;156(3):8–12.
Werner RN, Stockfleth E, Connolly SM, Correia O, Erdmann R, Foley P, et al. Evidence- and consensus-based (S3) guidelines for the treatment of actinic keratosis - international league of dermatological societies in cooperation with the European dermatology forum - short version. J Eur Acad Dermatol Venereol. 2015;29(11):2069–79.
Trost LB, Bailin PL. Cryosurgery. In: Vidimos AT, Ammirati CT, Poblete-Lopez C, editors. Dermatologic surgery. Philadelphia: Elsevier; 2009.
Kuflik EG, Kuflik JH. Cryosurgery. In: Bolognia JL, Jorizzo JL, Schaffer JV, editors. Dermatology. 3rd ed. Philadelphia: Elsevier; 2012.
Pomerantz H, Hogan D, Eilers D. Long-term efficacy of topical fluorouracil cream, 5%, for treating actinic keratosis. JAMA Dermatol. 2015;151(9):952–60.
Askew DA, Mickan SM, Soyer HP, Wilkinson D. Effectiveness of 5-fluorouracil treatment for actinic keratosis – a systemic review of randomized controlled trials. Int J Dermatol. 2009;48(5):453–63.
Ritchie SA, Patel MJ, Miller SJ. Therapeutic options to decrease actinic keratosis and squa- mous cell carcinoma incidence and progression in solid organ transplant recipients: a practical approach. Dermatol Surg. 2012 May;38(10):1604–21.
Hanna E, Abadi R, Abbas O. Imiquimod in dermatology: an overview. Int J Dermatol. 2016;55(8):831–44.
Stockfleth E. Lmax and imiquimod 3.75%: the new standard in AK management. J Eur Acad Dermatol Venereol. 2015;29(Supp.1):9–14.
Ulrich C, Bichel J, Euvrard S, Guidi B, Proby CM, et al. Topical immunomodulation under systemic immunosuppression: results of a multicentre, randomized, placebo-controlled safety and efficacy study of imiquimod 5% cream for the treatment of actinic keratosis in kidney, heart, and liver transplant patients. Br J Dermatol. 2007;157(Suppl 2):25–31.
Jenkins SN, Speck K, Actinic CSC. Keratosis and bowen’s disease. In: Bigby M, Herxheimer A, editors. Evidence based dermatology. 3rd ed. Chichester, England: Wiley-Blackwell; 2014.
Gold MH. Lasers, photodynamic therapy, and the treatment of medical dermatological conditions. In: Goldberg DJ, editor. Laser dermatology. New York: Springer Publishing; 2005.
Hantash BM, Stewart DB, Cooper ZA. Facial resurfacing for nonmelanoma skin cancer prophylaxis. Arch Dermatol. 2006;142(8):976–82.
Iyer SS, Friedli A, Bowes L, Kricorian G. Full face laser resurfacing: therapy and prophylaxis for actinic keratosis and non-melanoma skin cancer. Lasers Surg Med. 2004;34(2):114–9.
Criscione VD, Weinstock MA, Naylor MF, Luque C, Eide MJ, Bingham SF, Department of Veterans Affairs Topical Tretinoin Chemoprevention Trial Group. Natural history and risk of malignant transformation in the veterans affairs topical Tretinoin chemoprevention trial. Cancer. 2009;115(11):2523–30.
Quaedvlieg PJ, Tirsi E, Thissen MR, Krekels GA. Actinic keratosis: how to differentiate the good from the bad ones? Eur J Dermatol. 2006;16(4):335–9.
Madigan LM, Lim HW. Tanning beds: impact on health, and recent regulations. Clin Dermatol. 2016;34(5):640–8.
Nikolaou V, Stratigos AJ, Tsao H. Hereditary nonmelanoma skin cancer. Semin Cutan Med Surg. 2012;31(4):204–10.
Naylor MF, Boyd A, Smith DW, Cameron GS, Hubbard D, Neldner KH. High sun protection factor sunscreens in the suppression of actinic neoplasia. Arch Dermatol. 1995;131(2):170–5.
Darlington S, Williams G, Neale R, Frost C, Green A. A randomized controlled trial to assess sunscreen application and beta carotene supplementation in the prevention of solar keratoses. Arch Dermatol. 2003;139(4):451–5.
Thompson SC, Jolley D, Marks R. Reduction of solar keratoses by regular sunscreen use. N Engl J Med. 1993;329(16):1147–51.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Pye, A., Wallis, D., Mishra, V. (2018). Actinic Keratosis. In: Hanlon, A. (eds) A Practical Guide to Skin Cancer. Springer, Cham. https://doi.org/10.1007/978-3-319-74903-7_2
Download citation
DOI: https://doi.org/10.1007/978-3-319-74903-7_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-74901-3
Online ISBN: 978-3-319-74903-7
eBook Packages: MedicineMedicine (R0)